Core Viewpoint - Cronos Group Inc. will hold its 2025 fourth quarter and full-year earnings conference call on February 26, 2026, at 8:30 a.m. ET, where senior management will discuss financial results and answer questions from the investment community [1]. Group 1 - Participants can register for the conference call or webcast online and are encouraged to join fifteen minutes early to avoid delays [2]. - The webcast will be archived for replay on the Company's website [2]. Group 2 - Cronos is a global cannabinoid company focused on advancing cannabis research, technology, and product development, aiming to build a disruptive intellectual property portfolio [3]. - The Company is committed to enhancing the consumer experience and developing an iconic brand portfolio, which includes brands like Spinach, PEACE NATURALS, and Lord Jones [3].

For weed companies, cash is still king, credit cards are off limits and loans are prohibitive https://t.co/a1wWiMJea8 ...

Group 1 - The 420 Investor service, focused on cannabis stocks, has transitioned to Seeking Alpha, enhancing its coverage of the sector with model portfolios, videos, and written materials [1] - Organigram Global Inc. (OGI) was upgraded from Hold to Buy, while Village Farms (VFF) was downgraded from Sell to Strong Sell, indicating a shift in investment outlook for these companies [1] - Despite the upgrades, both stocks have declined in value over a 12-week period, prompting a reevaluation of Organigram's investment potential [1] Group 2 - Alan Brochstein, a pioneer in cannabis investment analysis, has been involved in the financial sector since 1986 and founded AB Analytical Services in 2007 to provide independent consulting [1] - Brochstein has managed the 420 Investor group since 2013, which closely monitors 19 cannabis stocks and provides timely investment news, earnings previews, and analyses [1] - The investing group features a model portfolio, 10 weekly videos with chart analysis, three weekly summary pieces, a monthly newsletter, and a chat function for investor inquiries [1]

Industry Overview - The cannabis industry is currently in a transitional phase, with over half of the US legalizing cannabis in some form, and the potential for all 50 states to establish a legal market, which could significantly impact marijuana stocks [1][2] - The sector has evolved, encompassing recreational, medical, and ancillary markets, as well as textile applications using hemp, indicating robust global growth [2] Market Outlook - Investors are speculating on how and when legal reforms will positively impact the sector, with positive speculation potentially driving trading momentum [3] - Proper preparation and careful observation of market trends can lead to profitable investment opportunities in marijuana stocks [3] Company Highlights - **Glass House Brands Inc.**: Operates as an integrated cannabis company in the US, with three segments: Retail, Wholesale Biomass, and Cannabis-Related Consumer Packaged Goods. The company appointed Alison Payne to its Board of Directors on January 27, 2026, enhancing its branding and marketing capabilities [4][5] - **Ayr Wellness Inc.**: Engages in the cultivation, manufacturing, and retailing of cannabis products. Recently, the company announced the departure of Lou Karger as Director and Chair of the Board, acknowledging his contributions to the company's development [8][9] - **Curaleaf Holdings, Inc.**: Produces and distributes cannabis products both domestically and internationally. The company has secured commitments for a private placement of US$500 million in senior secured notes, which will be used to refinance existing debt and support global growth initiatives [9][12]

Core Insights - Canopy Growth Corporation (CGC) reported a loss of 1 cent for Q3 fiscal 2026, a significant improvement from a loss of 76 cents in the same period last year, with sales remaining flat at $53.5 million (~C$75 million) [1][11] Financial Performance - Total cannabis revenues increased by 4% year over year, driven by strong performance in the Canadian market, which helped mitigate international volatility [3] - Canadian adult-use market sales rose by 8% year over year, supported by growth in infused pre-roll joints and new All-In-One vapes [4] - Medical cannabis sales in Canada grew by 15%, aided by an increase in insured patients and larger order volumes [4] - Overall gross margins decreased by 300 basis points to 29%, attributed to lower sales of higher-margin cannabis in international markets and increased inventory provisions [6] Market Dynamics - Canopy Growth's international cannabis division faced challenges due to supply-chain issues in Europe, leading to a decline in net revenues from its Storz & Bickel subsidiary [5] - The company anticipates continued strength in its Canadian cannabis business, with innovations in product offerings and expanding distribution [7] - Management expects sequential improvement in Europe as flower supply and strain availability increase, positioning the region as a growth driver [8] Competitive Landscape - Canopy Growth operates in a competitive market with players like Curaleaf Holdings and Tilray Brands, which are also expanding into international markets [9] - Increased competition may lead to aggressive market moves and further consolidation within the sector [9] Stock Performance and Outlook - Canopy Growth's shares have declined by 40% over the past year, compared to a 16% decline in the industry [12] - Management is targeting positive adjusted EBITDA by fiscal 2027, although overall business visibility remains limited due to international uncertainties and competitive pressures [11][16]

Core Viewpoint - Decibel Cannabis Company Inc. has granted 11,537,223 stock options to its officers and employees as part of its long-term compensation and employee retention program, with each option exercisable at a price of $0.10 per share, reflecting the closing price on February 10, 2026 [1]. Group 1 - The stock options will vest in three equal annual installments on January 1 in 2027, 2028, and 2029, and will expire on February 10, 2031 [1]. - Decibel is a market leader in premium cannabis and extract manufactured products, focusing on innovation and product quality [1]. - The company operates a processing and manufacturing facility in Calgary, Alberta, and has cultivation facilities in British Columbia, Saskatchewan, and Ontario [1]. Group 2 - Decibel's brands, including General Admission, Qwest, and Standard Issue, are sold across Canada and are beginning to expand into new international markets [1]. - The company emphasizes its commitment to delivering products that delight customers through robust innovation [1].

Group 1 - The article does not provide any relevant content regarding the company or industry [1]

Core Insights - Jeremy Szafron has joined Kitco News as an anchor and producer, bringing a wealth of experience in journalism, particularly in finance and current affairs [1][5] Background and Experience - Jeremy began his journalism career in 2006 at CTV, where he transitioned from entertainment reporting to business reporting, focusing on mining and small-cap companies [2] - He gained recognition for his macro-financial and market trends analysis, becoming a sought-after commentator on CTV Morning Live and a regular on CTV News Network [2] - A significant highlight of his career was covering the 2010 Vancouver Olympic Games, which led to the development of an online video news program for PressReader, a digital newsstand with 8,000 editions in 60 languages [3] Digital Media Ventures - In 2012, Jeremy launched The Green Scene Podcast, which quickly attracted over 400,000 subscribers and established him as a prominent voice in the cannabis industry [4] - Following this success, he created Investor Scene and Initiate Research, platforms that provide exclusive market insights and deal-flow opportunities in mining and Canadian small-cap sectors [4] Professional Roles - Jeremy has served as a market strategist and investor relations consultant for various publicly traded companies across mining, energy, consumer packaged goods (CPG), and technology industries [5] - He holds a BA in Journalism from Concordia University, which has supported his diverse career trajectory [5]

Core Viewpoint - Tilray Brands has significantly underperformed in the market, with a 98% decline in share value over the past five years compared to a 78% increase in the S&P 500 [1] Financial Performance - Tilray reported a net loss of $42 million for the six-month period ending November 30, 2025, an improvement from a $120 million loss in the same period the previous year, attributed to changes in fair value and lower amortization expenses [4] - The company's cash burn improved, using just under $10 million during the six-month period compared to over $76 million a year ago, indicating some progress in financial management [5] Market Outlook - The future of Tilray's stock is uncertain, with concerns that the company's aggressive growth strategy may not yield positive results, especially given the likelihood that U.S. marijuana legalization will not occur soon [6] - There is a prevailing sentiment that Tilray's stock could potentially go to $0 if financial conditions do not improve, particularly if liquidity issues arise [3][6] Investment Considerations - Tilray is viewed as a highly risky investment, with analysts suggesting that there are better and less risky growth stocks available for investors [7]

Core Insights - The article highlights Alan Brochstein's extensive experience in the investment industry, particularly his focus on the cannabis sector since 2014 [1] - Brochstein has contributed to the understanding of ETFs, emphasizing their role in diversified investment portfolios and risk awareness [1] Group 1: Professional Background - Alan Brochstein has been active in the financial sector since 1986, with a background in Economics and Mathematical Methods from Northwestern University [1] - He founded AB Analytical Services in 2007 to provide independent consulting to registered investment advisors [1] - Brochstein has been involved in both sell-side and buy-side roles in fixed-income and equities [1] Group 2: Cannabis Industry Focus - Brochstein was one of the first investment professionals to concentrate on the cannabis industry, starting in 2014 [1] - He launched 420 Investor in 2013, a subscription service focused on cannabis stocks, which is now part of the Seeking Alpha platform [1] - He is also the managing partner of New Cannabis Ventures, providing financial information in the cannabis industry since 2015 [1] Group 3: ETF Expertise - Brochstein has been writing about ETFs since 2025, aiming to help investors understand the ETF landscape [1] - He maintains a 79-ETF Focus List that includes both popular and lesser-known ETFs that stand out [1] - A model portfolio was created by Brochstein as of year-end 2025 to assist investors in managing their ETF investments [1]